Mar 31, 2019

Cogent Biosciences Q1 2019 Earnings Report

Total Revenue
$3.05M
Previous year: $2.22M
+37.5%
EPS
-$0.39
Previous year: -$0.66
-40.9%
Gross Profit
-$8.46M
Previous year: $2.22M
-480.9%
Cash and Equivalents
$59.1M
Previous year: $25.7M
+130.0%
Free Cash Flow
-$11.6M
Previous year: -$8.06M
+43.5%
Total Assets
$81.3M
Previous year: $43.4M
+87.2%

Cogent Biosciences

Cogent Biosciences

Cogent Biosciences Revenue by Segment